Indolent B-Cell Non-Hodgkin Lymphoma

Explore clinical trials studying Indolent B-Cell Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

9 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Indolent B-Cell Non-Hodgkin Lymphoma trial results

Recruiting

Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

NCT06386315

Conditions: Indolent B-Cell Non-Hodgkin Lymphoma, Recurrent Indolent B-Cell Non-Hodgkin Lymphoma, Recurrent Indolent Non-Hodgkin Lymphoma, +2 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic Health System in Albert Lea Albert Lea, Minnesota, United States

Mayo Clinic Health System - Mankato Mankato, Minnesota, United States

View Trial Details

Recruiting

SynKIR-310 for Relapsed/Refractory B-NHL

NCT06544265

Conditions: Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
Locations: Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States

Winship Cancer Institute of Emory University Atlanta, Georgia, United States

The University of Kansas Cancer Center Fairway, Kansas, United States

Rutgers Cancer Institute New Brunswick, New Jersey, United States

View Trial Details

Recruiting

A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHL

NCT03571568

Conditions: Indolent B-Cell Non-Hodgkin Lymphoma
Locations: Emory University Hospital Atlanta, Georgia, United States

Norton Cancer Institute - St. Matthews 3991 Dutchmans Lane Medical Plaza II, Suite 405 Louisville, Kentucky, United States

Hospital São Rafael Salvador, Estado de Bahia, Brazil

Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil

View all 27 locations

View Trial Details

Recruiting

Ga-68-CXCR4 PET/CT in Indolent B-cell Lymphoma

NCT06461182

Conditions: Indolent B-Cell Non-Hodgkin Lymphoma
Locations: Koo Foundation Sun Yat-Sen Cancer Center Taipei, Beitou, Taiwan

View Trial Details

Completed

Mosunetuzumab With or Without Polatuzumab Vedotin and Obinutuzumab for the Treatment of Untreated Indolent B-Cell Non-Hodgkin Lymphoma

NCT05169658

Conditions: Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma, +17 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

CC-486, Lenalidomide, and Obinutuzumab for the Treatment of Recurrent or Refractory CD20 Positive B-cell Lymphoma

NCT04578600

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +39 more
Locations: University of California Davis Comprehensive Cancer Center Sacramento, California, United States

View Trial Details

Active, Not Recruiting

Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies

NCT05665062

Conditions: CLL/SLL, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, +17 more
Locations: City of Hope Duarte, California, United States

Roswell Park Buffalo, New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

Cleveland Clinic Cleveland, Ohio, United States

View Trial Details

Active, Not Recruiting

ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma

NCT05025800

Conditions: Aggressive B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular Lymphoma, +31 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma

NCT05621096

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Follicular Lymphoma, +17 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Indolent B-Cell Non-Hodgkin Lymphoma

Indolent B-Cell Non-Hodgkin Lymphoma trial results

Related conditions